Free Trial

Genpact (NYSE:G) Issues FY 2025 Earnings Guidance

Genpact logo with Computer and Technology background

Key Points

  • Genpact updated its FY 2025 earnings guidance, projecting earnings per share between $3.510 and $3.580, surpassing the consensus estimate of $3.472.
  • The company provided revenue guidance of $5.0 billion to $5.1 billion, aligning with the consensus estimate of $5.0 billion.
  • Genpact recently announced a quarterly dividend of $0.17 per share, with a dividend yield of 1.6% planned for payment on September 25th.
  • Want stock alerts on Genpact? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Genpact (NYSE:G - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 3.510-3.580 for the period, compared to the consensus earnings per share estimate of 3.472. The company issued revenue guidance of $5.0 billion-$5.1 billion, compared to the consensus revenue estimate of $5.0 billion. Genpact also updated its Q3 2025 guidance to 0.890-0.900 EPS.

Wall Street Analysts Forecast Growth

G has been the subject of a number of recent research reports. Mizuho boosted their target price on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Robert W. Baird cut their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Wall Street Zen raised Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Needham & Company LLC restated a "buy" rating and set a $50.00 target price on shares of Genpact in a report on Monday, June 30th. Finally, Deutsche Bank Aktiengesellschaft started coverage on Genpact in a research report on Thursday, July 17th. They set a "hold" rating and a $47.00 price target on the stock. Five research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $49.75.

Get Our Latest Stock Analysis on Genpact

Genpact Trading Down 1.3%

Genpact stock traded down $0.53 during mid-day trading on Thursday, reaching $41.67. 3,073,765 shares of the company traded hands, compared to its average volume of 1,601,989. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.45 and a quick ratio of 2.45. Genpact has a 52-week low of $32.18 and a 52-week high of $56.76. The firm has a market capitalization of $7.29 billion, a price-to-earnings ratio of 14.22, a P/E/G ratio of 1.61 and a beta of 0.92. The firm's 50 day moving average price is $43.84 and its 200 day moving average price is $47.12.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.76 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.85 by ($0.09). Genpact had a return on equity of 22.35% and a net margin of 10.88%. On average, analysts anticipate that Genpact will post 3.21 earnings per share for the current fiscal year.

Genpact Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio (DPR) is presently 23.21%.

Insider Activity at Genpact

In related news, Director Nicholas C. Gangestad purchased 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The stock was purchased at an average price of $43.97 per share, with a total value of $87,940.00. Following the transaction, the director directly owned 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 3.07% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Genpact

Several institutional investors and hedge funds have recently made changes to their positions in G. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Genpact by 12.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock valued at $25,776,000 after acquiring an additional 56,557 shares during the period. Goldman Sachs Group Inc. lifted its position in Genpact by 20.8% during the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider's stock valued at $17,788,000 after purchasing an additional 60,887 shares during the period. Royal Bank of Canada boosted its holdings in Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider's stock worth $6,131,000 after purchasing an additional 20,043 shares during the last quarter. Focus Partners Wealth grew its position in Genpact by 10.3% in the 1st quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock worth $263,000 after purchasing an additional 488 shares during the period. Finally, Amundi purchased a new stake in Genpact during the 1st quarter valued at $58,000. Institutional investors own 96.03% of the company's stock.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Earnings History and Estimates for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

7 Nuclear Stocks One Announcement Away from Exploding
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines